ADVISORY/Institute for Global Health Will Present Action Steps for a Universal Approach to Treating and Preventing Disease in Developing Nations.News/Assignment Editors and Medical/Health Writers ADVISORY...for Tuesday (Feb. 22) --(BW HealthWire) Academic, Corporate and World Health Leaders Express Urgency for Developing Drugs and Vaccines During Important Bay Area Forum
What: UCSF Press Briefing on Global Health Issues and
Recommendations
When: 9:30 to 10:30 am, Tuesday, Feb. 22
Where: Institute for Global Health
5th Floor International Conference Room (Suite 508)
74 New Montgomery St., San Francisco
OR
To participate by phone, call 888/447-1160 in the U.S.
Callers outside the U.S. dial 303/633-7018
Who: Panelists of international health leaders, including:
-- Dr. Richard Feachem, founding director, Institute for Global
Health
-- Dr. Dean Jamison, chief economist, World Health Organization
-- Dr. Jacques-Francois Martin, a leading figure in Europe's vaccine
industry
-- Dr. Hannah Kettler, Office of Health Economics, London
Media are invited to attend or participate in the press briefing via telephone. Copies of the recommendations, as well as the pre-forum briefing booklet, will be made available to reporters at the briefing. For more information, call UCSF UCSF University of California at San Francisco News Services at 415/476-2557. Background The potential of biomedical science Noun 1. biomedical science - the application of the principles of the natural sciences to medicine bioscience, life science - any of the branches of natural science dealing with the structure and behavior of living organisms and biotechnology to deliver powerful new drugs and vaccines continues to grow. Today, however, the great majority of research and development in both public and private laboratories are devoted to diseases that afflict af·flict tr.v. af·flict·ed, af·flict·ing, af·flicts To inflict grievous physical or mental suffering on. [Middle English afflighten, from afflight, the rich, according to according to prep. 1. As stated or indicated by; on the authority of: according to historians. 2. In keeping with: according to instructions. 3. Richard Feachem Sir Richard George Andrew Feachem, KBE, FREng was born in Manchester, UK in 1947. He took up his position as the first Executive Director of the Global Fund to Fight AIDS, Tuberculosis and Malaria, and Under Secretary-General of the United Nations, in July 2002. , Ph.D., DSc(Med), founding director of the UCSF Institute for Global Health, and a professor of international health at UCSF and UC Berkeley. "Powerful new drugs and vaccines are being developed and delivered much more quickly than ever before," he says. "We must find ways to harness the momentum to bring medicines to all people in the world who could benefit from them." Feachem was formerly director for Health, Nutrition and Population at the World Bank and dean of the London School of Hygiene hygiene, science of preserving and promoting the health of both the individual and the community. It has many aspects: personal hygiene (proper living habits, cleanliness of body and clothing, healthful diet, a balanced regimen of rest and exercise); domestic hygiene and Tropical Medicine tropical medicine, study, diagnosis, treatment, and prevention of certain diseases prevalent in the tropics. The warmth and humidity of the tropics and the often unsanitary conditions under which so many people in those areas live contribute to the development and . When a new product is brought to market in developed countries that would also benefit the people of poorer countries, there is typically a delay of a decade or more before this product is widely available to all those who need it. Feachem cites the hepatitis B vaccine hepatitis B vaccine n. Abbr. HB A vaccine prepared from the inactivated surface antigen of the hepatitis B virus and used to immunize against hepatitis B. and drugs against HIV HIV (Human Immunodeficiency Virus), either of two closely related retroviruses that invade T-helper lymphocytes and are responsible for AIDS. There are two types of HIV: HIV-1 and HIV-2. HIV-1 is responsible for the vast majority of AIDS in the United States. as examples of deadly delays in treating the ill in developing nations. To discuss ongoing and newly-launched initiatives in global health and to outline recommendations for the future, the Institute designed a forum of top-level experts, public officials and industry leaders that will meet in the Bay Area this weekend (Feb. 18-21). Participants include ministers of both India and Indonesia, executives from Merck and Co. Inc., Glaxo-Wellcome and other biopharmaceutical companies, and senior representatives from the World Bank, World Trade Organization, and the World Health Organization. (For names and titles of participants, reporters should call UCSF News Services). |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion